Uncategorized
NovaBay reports lower net loss in 2016
NovaBay Pharmaceuticals reported a net loss of $13.2 million, or $1.40 per share, in 2016 compared with a net loss of $19 million, or $6.82 per share, in 2015, according to a company press release.In the fourth quarter, the company had a net loss of $1.6 million, or $0.11 per share, compared with a net loss of $4.2 million, or $1.26 per share, in the same time period the previous year.